Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux

Journal of Lipid Research

Volumn 50, Issue 10, 2009, Pages 2046-2054

  Vrins, Carlos L J ^a   van der Velde, Astrid E ^a   van den Oever, Karin ^a   Levels, Johannes H M ^a   Huet, Stephane ^b   Oude Elferink, Ronald P J ^a   Kuipers, Folkert ^c   Groen, Albert K ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b GLAXOSMITHKLINE   (France)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Intestine; Reverse cholesterol transport; Transintestinal cholesterol efflux

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ABC TRANSPORTER G5; ABC TRANSPORTER G8; ACYL COENZYME A DESATURASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; EZETIMIBE; NIEMANN PICK C1 LIKE 1 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PHOSPHOLIPID; PROTEIN INTERACTING WITH PROTEIN KINASE C; PROTEIN RAB9; RAB PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BILE FLOW; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; INTESTINE PERFUSION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SODIUM EXCRETION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CHOLESTEROL; EATING; INTESTINES; LIPOPROTEINS; LIVER; MALE; MICE; PPAR DELTA; RNA, MESSENGER; THIAZOLES;

EID: 70350370460     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800579-JLR200     Document Type: Article

References (39)

1. Lemberger, T., B. Desvergne, and W. Wahli. 1996. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol. 12: 335-363.
2. Dreyer, C., G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli. 1992. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 68: 879-887.
3. Gulick, T., S. Cresci, T. Caira, D. D. Moore, and D. P. Kelly. 1994. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl. Acad. Sci. USA. 91: 11012-11016.
4. Rodriguez, J. C., G. Gil-Gomez, F. G. Hegardt, and D. Haro. 1994. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J. Biol. Chem. 269: 18767-18772.
5. Tugwood, J. D., I. Issemann, R. G. Anderson, K. R. Bundell, W. L. McPheat, and S. Green. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11: 433-439.
6. Issemann, I., and S. Green. 1991. Cloning of novel members of the steroid hormone receptor superfamily. J. Steroid Biochem. Mol. Biol. 40: 263-269.
7. Graves, R. A., P. Tontonoz, and B. M. Spiegelman. 1992. Analysis of a tissue-specifi c enhancer: ARF6 regulates adipogenic gene expression. Mol. Cell. Biol. 12: 3313.
8. Erranz, B., J. F. Miquel, W. S. Argraves, J. L. Barth, F. Pimentel, and M. P. Marzolo. 2004. Megalin and cubilin expression in gallbladder epithelium and regulation by bile acids. J. Lipid Res. 45: 2185-2198.
9. Tontonoz, P., E. Hu, J. Devine, E. G. Beale, and B. M. Spiegelman. 1995. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 15: 351-357.
10. Braissant, O., F. Foufelle, C. Scotto, M. Dauca, and W. Wahli. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 137: 354-366.
11. Amri, E. Z., F. Bonino, G. Ailhaud, N. A. Abumrad, and P. A. Grimaldi. 1995. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J. Biol. Chem. 270: 2367-2371.
12. Barak, Y., D. Liao, W. He, E. S. Ong, M. C. Nelson, J. M. Olefsky, R. Boland, and R. M. Evans. 2002. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. USA. 99: 303-308.
13. Peters, J. M., S. S. Lee, W. Li, J. M. Ward, O. Gavrilova, C. Everett, M. L. Reitman, L. D. Hudson, and F. J. Gonzalez. 2000. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol. Cell. Biol. 20: 5119-5128.
14. Tanaka, T., J. Yamamoto, S. Iwasaki, H. Asaba, H. Hamura, Y. Ikeda, M. Watanabe, K. Magoori, R. X. Ioka, K. Tachibana, et al. 2003. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc. Natl. Acad. Sci. USA. 100: 15924-15929.
15. Wang, Y. X., C. H. Lee, S. Tiep, R. T. Yu, J. Ham, H. Kang, and R. M. Evans. 2003. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell. 113: 159-170.
16. Wang, Y. X., C. L. Zhang, R. T. Yu, H. K. Cho, M. C. Nelson, C. R. Bayuga-Ocampo, J. Ham, H. Kang, and R. M. Evans. 2004. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol. 2: e294.
17. Takahashi, S., T. Tanaka, T. Kodama, and J. Sakai. 2006. Peroxisome proliferator-activated receptor delta (PPARdelta), a novel target site for drug discovery in metabolic syndrome. Pharmacol. Res. 53: 501-507.
18. Oliver, W. R., Jr., J. L. Shenk, M. R. Snaith, C. S. Russell, K. D. Plunket, N. L. Bodkin, M. C. Lewis, D. A. Winegar, M. L. Sznaidman, M. H. Lambert, et al. 2001. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc. Natl. Acad. Sci. USA. 98: 5306-5311.
19. Sprecher, D. L., C. Massien, G. Pearce, A. N. Billin, I. Perlstein, T. M. Willson, D. G. Hassall, N. Ancellin, S. D. Patterson, D. C. Lobe, et al. 2007. Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist. Arterioscler. Thromb. Vasc. Biol. 27: 359-365.
20. van der Veen, J. N., J. K. Kruit, R. Havinga, J. F. Baller, G. Chimini, S. Lestavel, B. Staels, P. H. Groot, A. K. Groen, and F. Kuipers. 2005. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. J. Lipid Res. 46: 526-534.
21. Altmann, S. W., H. R. Davis, Jr., L. J. Zhu, X. Yao, L. M. Hoos, G. Tetzloff, S. P. Iyer, M. Maguire, A. Golovko, M. Zeng, et al. 2004. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 303: 1201-1204.
22. van, der Valde, A. E., C. L. Vrins, K. van den Oever, C. Kunne, R. P. Oude Elferink, F. Kuipers, and A. K. Groen. 2007. Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice. Gastroenterology. 133: 967-975.
23. Levels, J. H., D. Pajkrt, M. Schultz, F. J. Hoek, A. van Tol, J. C. Meijers, and S. J. van Deventer. 2007. Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis. Biochim. Biophys. Acta. 1771: 1429-1438.
24. Bligh, E. G. and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
25. Huang, H., J. W. Kauan, and G. G. Guilbault. 1975. Fluorometric enzymatic determination of total cholesterol in serum. Clin. Chem. 21: 1605-1608.
26. Gurantz, D., M. F. Laker, and A. F. Hofmann. 1981. Enzymatic measurement of choline-containing phospholipids in bile. J. Lipid Res. 22: 373-376.
27. Turley, S. D., and J. M. Dietschy. 1978. Re-evaluation of the 3 alpha-hydroxysteroid dehydrogenase assay for total bile acids in bile. J. Lipid Res. 19: 924-928.
28. Gerhardt, K. O., C. W. Gehrke, I. T. Rogers, M. A. Flynn, and D. J. Hentges. 1977. Gas-liquid chromatography of fecal neutral steriods. J. Chromatogr. 135: 341-349.
29. Faiola, B., J. G. Falls, R. A. Peterson, N. R. Bordelon, T. A. Brodie, C. A. Cummings, E. H. Romach, and R. T. Miller. 2008. PPAR alpha, more than PPAR delta, mediates the hepatic and skeletal muscle alterations induced by the PPAR agonist GW0742. Toxicol. Sci. 105: 384-394.
30. Ge, L., J. Wang, W. Qi, H. H. Miao, J. Cao, Y. X. Qu, B. L. Li, and B. L. Song. 2008. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab. 7: 508-519.
31. Linder, M. D., R. L. Uronen, M. Hölttä-Vuori, P. van der Sluijs, J. Peränen, and E. Ikonen. 2007. Rab8-dependent recycling promotes endosomal cholesterol removal in normal and sphingolipidosis cells. Mol. Biol. Cell. 18: 47-56.
32. Narita, K., A. Choudhury, K. Dobrenis, D. K. Sharma, E. L. Holicky, D. L. Marks, S. U. Walkley, and R. E. Pagano. 2005. Protein transduction of Rab9 in Niemann-Pick C cells reduces cholesterol storage. FASEB J. 19: 1558-1560.
33. Temel, R. E., W. Tang, Y. Ma, L. L. Rudel, M. C. Willingham, Y. A. Ioannou, J. P. Davies, L. M. Nilsson, and L. Yu. 2007. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J. Clin. Invest. 117: 1968-1978.
34. Graham, T. L., C. Mookherjee, K. E. Suckling, C. N. Palmer, and L. Patel. 2005. The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice. Atherosclerosis. 181: 29-37.
35. Labonte, E. D., L. M. Camarota, J. C. Rojas, R. J. Jandacek, D. E. Gilham, J. P. Davies, Y. A. Ioannou, P. Tso, D. Y. Hui, and P. N. Howles. 2008. Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G776-G783
36. Choudhury, A., M. Dominguez, V. Puri, D. K. Sharma, K. Narita, C. L. Wheatley, D. L. Marks, and R. E. Pagano. 2002. Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid traffi cking in Niemann-Pick C cells. J. Clin. Invest. 109: 1541-1550.
37. Eskelinen, E. L., Y. Tanaka, and P. Saftig. 2003. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 13: 137-145.
38. Eckhardt, E. R., L. Cai, B. Sun, N. R. Webb, and D. R. van der Westhuyzen. 2004. High density lipoprotein uptake by scavenger receptor SR-BII. J. Biol. Chem. 279: 14372-14381.
39. van der Velde, A. E., C. L. Vrins, K. van den Oever, I. Seemann, R. P. Oude Elferink, M. van Eck, F. Kuipers, and A. K. Groen. 2008. Regulation of direct transintestinal cholesterol excretion in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G203-G208.